Government interrogates prices to stymie £200m-plus drugs overspend

By Sharon Brennan2018-02-23T12:00:00

Government has begun intensively monitoring new information on the generic drug market to try to stymie additional costs which are running into hundreds of millions of pounds, HSJ has been told.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here